France (1) Marketing (1) Children (1) Olanzapine (1) Risperidone (1) Clozapine (1) Antipsychotic drugs (1) Teenagers (1) Biological monitoring (1) Tranquilizing drugs (1) Toleration (1) Symptoms (1) Schizophrenia (1) Risk (1) Necessity (Philosophy) (1) Molecules (1) Manic-depressive illness (1) Embargo (1) Depression, Mental (1) Clinical trials (1) Use studies (1) Use studies (1) Administration (1) Side effects (1) Processing (1) Effectiveness (1) Risperidona (1) Ansiolíticos (1) Trastornos bipolares (1) Clozapina (1)